These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7685428)

  • 21. Efficacy and tolerability of Casodex in patients with advanced prostate cancer. International Casodex Study Group.
    Lunglmayr G
    Anticancer Drugs; 1995 Aug; 6(4):508-13. PubMed ID: 7579554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bicalutamide on prostate histology.
    Eri LM; Svindland A; Tveter KJ
    Prostate; 2001 Mar; 46(4):275-80. PubMed ID: 11241549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised study of Casodex 50 MG monotherapy vs orchidectomy in the treatment of metastatic prostate cancer. The Scandinavian Casodex Cooperative Group.
    Iversen P; Tveter K; Varenhorst E
    Scand J Urol Nephrol; 1996 Apr; 30(2):93-8. PubMed ID: 8738052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the nonsteroidal anti-androgen Casodex in advanced prostatic carcinoma.
    Kennealey GT; Furr BJ
    Urol Clin North Am; 1991 Feb; 18(1):99-110. PubMed ID: 1992575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
    Furr BJ
    Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monitoring of erection function in patients with prostatic carcinoma treated with Casodex].
    Migliari R; Muscas G; Melis M; Garau M; Sorgia M; Scarpa RM; Usai E
    Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):155-61. PubMed ID: 1830408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
    Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
    N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saw palmetto for benign prostatic hyperplasia.
    Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL
    N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.
    Ostri P; Swartz R; Meyhoff HH; Petersen JH; Lindgård G; Frimodt-Møller C; Andersson T; Nielsen MS
    Urol Res; 1989; 17(1):29-33. PubMed ID: 2466359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
    Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].
    Rusakov IG; Alekseev BIa
    Urologiia; 2002; (5):23-6. PubMed ID: 12402771
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.
    Bosch RJ; Griffiths DJ; Blom JH; Schroeder FH
    J Urol; 1989 Jan; 141(1):68-72. PubMed ID: 2462067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS].
    Ohtani M; Kikuchi K; Tsuchiya A; Noguchi R; Akaza H; Kondo F; Koiso K
    Hinyokika Kiyo; 2000 Nov; 46(11):791-7. PubMed ID: 11193299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
    Schellhammer PF; Sharifi R; Block NL; Soloway MS; Venner PM; Patterson AL; Sarosdy MF; Vogelzang NJ; Chen Y; Kolvenbag GJ
    Cancer; 1996 Nov; 78(10):2164-9. PubMed ID: 8918410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Casodex on sleep-related erections in patients with advanced prostate cancer.
    Migliari R; Muscas G; Usai E
    J Urol; 1992 Aug; 148(2 Pt 1):338-41. PubMed ID: 1378907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study.
    Caine M; Perlberg S; Gordon R
    J Urol; 1975 Oct; 114(4):564-8. PubMed ID: 66331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China.
    Shi R; Xie Q; Gang X; Lun J; Cheng L; Pantuck A; Rao J
    J Urol; 2008 Feb; 179(2):610-5. PubMed ID: 18082217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.